ClinicalTrialsFinder

Peptide Receptor Radionuclide Therapy Clinical Trials in Rotterdam, South Holland

1 recruitingRotterdam, South Holland, Netherlands

Showing 1–1 of 1 trials

Recruiting
Phase 1

Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors

Neuroendocrine TumorsPeptide Receptor Radionuclide Therapy
Erasmus Medical Center24 enrolled1 locationNCT05870423